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Background and Purpose: Internal carotid artery stenosis (ICAS)≥70% is a leading
cause of ischemic cerebrovascular events (ICVEs). However, a considerable percentage
of stroke survivors with symptomatic ICAS (sICAS) have<70% stenosis with a vulnerable
plaque. Whether the length of ICAS is associated with high risk of ICVEs is poorly
investigated. Our main aim was to investigate the relation between the length of ICAS
and the development of ICVEs.
Methods: In a retrospective cross-sectional study, we identified 95 arteries with sICAS
and another 64 with asymptomatic internal carotid artery stenosis (aICAS) among 121
patients with ICVEs. The degree and length of ICAS as well as plaque echolucency were
assessed on ultrasound scans.
Results: A statistically significant inverse correlation between the ultrasound-measured
length and degree of ICAS was detected for sICAS≥70% (Spearman correlation
coefficient ρ = –0.57, p < 0.001, n = 51) but neither for sICAS<70% (ρ = 0.15,
p = 0.45, n = 27) nor for aICAS (ρ = 0.07, p = 0.64, n = 54). The median (IQR)
length for sICAS<70% and ≥70% was 17 (15–20) and 15 (12–19) mm (p = 0.06),
respectively, while that for sICAS<90% and sICAS 90% was 18 (15–21) and 13 (10–16)
mm, respectively (p < 0.001). Among patients with ICAS<70%, a cut-off length of ≥16
mmwas found for sICAS rather than aICAS with a sensitivity and specificity of 74.1% and
51.1%, respectively. Irrespective of the stenotic degree, plaques of the sICAS compared
to aICAS were significantly more often echolucent (43.2 vs. 24.6%, p = 0.02).
Conclusion: We found a statistically insignificant tendency for the ultrasound-measured
length of sICAS<70% to be longer than that of sICAS≥70%. Moreover, the
ultrasound-measured length of sICAS<90% was significantly longer than that of sICAS
90%. Among patients with sICAS≥70%, the degree and length of stenosis were inversely
correlated. Larger studies are needed before a clinical implication can be drawn from
these results.
Keywords: ischemic stroke, carotid stenosis, carotid atherosclerosis, length of stenosis, degree of stenosis,
carotid ultrasound, outcome
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INTRODUCTION
Internal carotid artery stenosis (ICAS) causes around one-fifth of
ischemic cerebrovascular stroke and has the highest risk of early
stroke recurrence in comparison to other stroke subtypes such as
cardioembolism or small artery occlusion (1–3). There is a large
body of literature showing that the risk of ICAS-related stroke
recurrence correlates with the degree of stenosis; ICAS≥70%
bears a higher risk compared to ICAS<70% (4). However, there is
growing evidence that also low-grade ICAS may lead to ischemic
cerebrovascular events (ICVEs) (5, 6). This observation raises the
hypothesis that atherosclerotic plaques become unstable because
of other characteristics (e.g., plaque composition) and may be
finally prone to rupture (“vulnerable carotid plaque concept”) (7).
This—in turn–may result in microemboli originating from the
surface of plaque. Imaging or pathological biomarkers of plaque,
such as fibrous caps, lipid-rich core, and intraplaque hemorrhage
have been proposed as indicators of high stroke risk (8).
Duplex ultrasonography is a well-established method to assess
the degree of ICAS as well as plaque morphology. Especially,
echolucent carotid plaques are often associated with an increased
risk for transient ischemic attacks (TIA) and ischemic strokes
(9, 10). However, whether the length of ICAS contributes also to
the occurrence of stroke is poorly investigated.
In the present study, we aimed to investigate whether (i) the
length of ICAS is related to the occurrence of stroke or TIA
among patients with sICAS; (ii) there is a relationship between
length and degree of ICAS, and whether (iii) plaque echolucency
of ICAS<70% is related to stroke or TIA occurrence among
patients with sICAS.
MATERIALS AND METHODS
Inclusion and Exclusion Criteria
The raw data supporting the conclusions of this manuscript will
be made available by the authors, without undue reservation,
to any qualified researcher. We conducted a retrospective
cohort study at the Department of Neurology, University
Hospital of Würzburg. From January 2011 until September 2016,
121 patients with an ischemic stroke or TIA as well as an
asymptomatic or symptomatic ICAS were enrolled in this study.
The diagnosis of ICAS was based on ultrasound examination.
All patients received electrocardiographic monitoring with
atrial fibrillation alarm for a minimum of 24 h. Stroke was
diagnosed based on the detection of brain infarction either
in the computed tomography or magnetic resonance imaging
of the brain and/or the presence of focal neurological signs
lasting longer than 24 h (11). Transient ischemic attack (TIA)
was diagnosed according to the definition of the American
Heart Association/American Stroke Association (AHA/ASA): a
transient episode of neurological dysfunction caused by focal
brain, spinal cord or retinal ischemia, without acute infarction
(12). The ICAS was classified as symptomatic, if the ICVE
occurred in the territory of the respective internal carotid artery
(ICA). Conversely, the ICAS was classified as asymptomatic,
if the ICVE affected the territory of the contralateral ICA or
the vertebrobasilar territory. The exclusion criteria were: (1)
carotid artery occlusion or pseudo-occlusion because in this
case, the measurement of the stenotic length is not possible, (2)
patients with merely common carotid artery stenosis without
affection of the internal carotid artery, (3) ICAS of 10%,measured
according to the hemodynamic criteria of the North American
Symptomatic Carotid Endarterectomy Trial (NASCET) (13),
because many of these cases could have been easily missed from
our records, (4) patients admitted after onset of the ICVE, (5)
iatrogenic stroke occurring after carotid endarterectomy or after
coronary angiography, (6) no available ultrasound scans of the
ICAS, and (7) patients in whom the classification of ICAS as
symptomatic or asymptomatic was not possible; this included: (a)
patients with brain infarctions ipsilateral to ICAS in the presence
of another cardioembolic source according to Trial of Org 10172
in Acute Stroke Treatment (TOAST) (14), lacunar infarction
or stroke of other etiology and (b) patients with bilateral brain
infarctions, with the main infarction bulk located ipsilateral to
the ICAS with further small brain infarction(s) located in the
contralateral cerebral hemisphere.
Measurement of the Degree of Stenosis
and Assessment of Plaque Morphology
Ultrasound examination was conducted on a Toshiba AplioXG
machine (Toshiba Medical Systems Corporation, Tochigi,
Japan) using a 7.5 MHz linear transducer. The degree of ICAS
was measured according to the hemodynamic criteria of the
North American Symptomatic Carotid Endarterectomy Trial
(NASCET) (13). ICAS was categorized into ICAS<70% and
ICAS≥70% and further into <90% and 90%. Visual analysis
of plaque echolucency on B-mode images was performed by
a single observer (AME) using the modified classification
proposed by Gray-Weale (15): type 1 (predominantly
echolucent), type 2 (mixed echolucent/echogenic), and type
3 (predominantly echogenic).
Measurement of the Length of Stenosis
The length of ICAS was measured by a single observer (AME)
on ultrasound images, which were used as the standard for
all statistical analyses. We chose ultrasound as the standard
examination because all patients included in this study had
available ultrasound images. If the corresponding imaging
modalities were available, the length was also measured
on magnetic resonance angiography (MRA) and/or digital
subtraction angiography (DSA) scans. The two later modalities
were used for comparative reasons but not included in the
analysis of the statistical relation between the ICVE and the
length of ICAS. To measure the length, we chose the projection
demonstrating the longest stenotic segment. The length was
measured from the most proximal to the most distal part of the
stenotic segment as shown in Figure 1. In the ultrasound images,
the most proximal and the most distal stenotic segments were
defined according to the following criteria: 1. visible narrowing
of the vascular lumen, 2. aliasing phenomenon in the proximal
end of stenosis. For the distal end, an aliasing phenomenon was
accepted, only in the presence of corresponding images showing
increased systolic flow velocity denoting the presence of stenosis.
In absence of corresponding increased systolic flow velocity,
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FIGURE 1 | Assessment of the length of internal carotid artery stenosis. A
representative example of a duplex scan (B-mode).The length of stenosis was
measured from the most proximal to the most distal stenotic area (indicated by
a dashed yellow double arrowhead).
criteria 1 and 3 were used to identify the distal end, because the
differentiation between aliasing due to stenosis and post-stenotic
flow disturbance was not possible, or 3. the presence of severe
calcification, interfering with the visualization of the vascular
lumen. In the MRA and DSA scans, criteria one was used to
identify the most proximal and most distal stenotic ends.
Statistical Analyses
Quantitative data were expressed using mean and standard
deviation (SD) and/or median and interquartile range, while
qualitative data were expressed in absolute and relative
frequencies. To check for normality, we used graphical methods
(QQ-plot and histogram) and the Shapiro-Wilk test. Univariable
statistical tests were conducted using χ2 test for categorical
data and Mann-Whitney U-test as well as Kruskal-Wallis test
for continuous data. Spearman coefficient was used to analyze
correlations. For the statistical analyses concerning the length
of ICAS, the ultrasound-measured length was used, because all
included cases had available ultrasound images. We calculated
the sensitivity and specificity of all ultrasound-measured length
values using a receiver operating characteristic (ROC)-curve
and chose the point with best sensitivity and specificity to
represent the cut-off-value differentiating between symptomatic
and asymptomatic ICAS. Data were analyzed in SPSS software
package version 24 (SPSS, Chicago, IL, USA). P-values <0.05
were considered statistically significant.
RESULTS
Of the 489 screened patients, 121 patients with 159 ICAS met our
inclusion criteria. Causes of exclusion are shown in Figure 2 and
baseline data in Table 1. The length of stenosis was measured in
134/159 ICAS using ultrasound, in 97/99 ICAS using MRA and
in 23/23 ICAS using DSA. The ultrasound scans were used to
assess both the degree of stenosis in 157/159 ICAS and plaque
echolucency in 149/159 arteries. Ninety-five ICAS (59.7%) were
classified as symptomatic and 64 (40.3%) as asymptomatic. The
median degree of all measured carotid artery stenoses was 60%
(IQR 20%-80%). The median length was 16 (IQR 12–20), 10
(IQR 8–13), and 13 (IQR 10–17) mm in ultrasound, MRA
and DSA, respectively. When comparing the imaging modalities
with respect to the assessment of the length of stenosis, we
found a statistically significant positive correlation between the
ultrasound- and MRA-measured length (ρ = 0.35, p = 0.002,
n = 76). A trend for a positive correlation was observed between
MRA- and DSA-measured length (ρ = 0.52, p = 0.06, n = 14).
The correlation between the ultrasound- and DSA-measured
length was not statistically significant (ρ = 0.46, p= 0.1, n= 14).
Neurosonological examination revealed a significantly higher
degree of sICAS with a median of 80 (IQR, 50–90)% compared to
20 (IQR, 20–50)% for aICAS (p< 0.001). Overall, the ultrasound-
measured length of sICAS and aICAS were similar; median 17
(IQR, 12–20) mm vs. 16 (IQR, 12–19) mm, p= 0.66 (Table 2).
The Relation Between the Length of sICAS
and aICAS Among Patients With <70 vs.
≥70% ICAS
ICAS was divided according to the degree of stenosis into <70%
or ≥70%. The ultrasound-measured length of sICAS<70% was
insignificantly longer than that of sICAS≥70%; median 17 (IQR
15–20) mm vs. 15 (IQR 12–19) mm, respectively, p = 0.06
(Figure 3). An inverse relationship was observed between the
degree measured in duplex and length of sICAS measured by
duplex sonography (ρ = –0.39, p < 0.001, n = 78), MRA
(ρ = –0.24, p = 0.07, n = 60), and DSA (ρ = –0.12, p = 0.67,
n = 15). Further analyses yielded only an inverse correlation
among sICAS≥70% (duplex sonography, ρ = –0.57, p < 0.001,
n = 51; MRA, ρ = –0.38, p = 0.01, n = 44 and DSA,
ρ = –0.37, p = 0.22, n = 13). However, among sICAS<70%,
such inverse correlations were no longer observed (duplex
sonography, ρ = 0.15, p = 0.45, n = 27 and MRA, ρ = 0.54,
p = 0.03, n = 16). There were only two available DSA images
for sICAS≥70%; therefore, a measurement of the correlation
coefficient was not possible. The relation between the ultrasound-
measured degree and length of sICAS is shown in Figure 4.
On the asymptomatic side, no statistically significant
differences were found regarding the length of stenosis
(aICAS<70%, median 15 (IQR 12–19) mm; aICAS≥70%,
median 18 (IQR 11–20) mm; p = 0.74) (Table 2 and Figure 3).
The correlations between the degree, as measured in duplex, and
the length of aICAS, as measured in duplex, MRA and DSA were
not statistically significant (ρ = 0.07, p= 0.64, n= 54), (ρ = 0.15,
p= 0.38, n= 36), and (ρ = 0.39, p= 0.39, n= 7), respectively.
Furthermore, among arteries with ICAS<70%, an ultrasound-
measured length of ≥16 mm was observed among sICAS
rather than aICAS with a sensitivity and specificity of 74.1 and
51.1%, respectively.
The Relation Between the Length of sICAS
and aICAS Among Patients With <90 vs.
90% ICAS
Among patients with ICAS<90%, a statistically significant
difference between the ultrasound-measured length of sICAS
and observed; median (IQR) for sICAS was 16 (12–19) mm
vs. 18 (IQR 15–21) mm for aICAS (p = 0.03) (Figure 5).
Furthermore, a statistically significant difference between the
ultrasound-measured length of sICAS<90% and sICAS 90% was
observed; median 18 (IQR 15–21) and 13 (IQR 10–16) mm,
respectively (p< 0.001) (Figure 4).
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FIGURE 2 | Flow chart showing the included and excluded patients from the current study. CA, carotid artery; CCA, common carotid artery; ICA, internal carotid
artery; ICAS, internal carotid artery stenosis; TIA, transient ischemic attack, iatrogenic stroke (5 cases after carotid endarterectomy, 1 case after coronary
angiography). Of the 489 patients screened, only 121 patients met our inclusion and exclusion criteria.
Difference of Plaque Echolucency Between
sICAS and aICAS
Irrespective of the stenotic degree, sICAS was more often
echolucent compared to aICAS (43.2 vs. 24.6%, p = 0.02).
Echogenic plaques were more associated with aICAS
(symptomatic vs. asymptomatic side: 40.9 vs. 67.2%, p = 0.002)
(Table 2). In patients with ICAS<70%, echolucent plaques were
detected in 41.4% of sICAS and in 23.1% of aICAS (p = 0.08). In
contrast, echogenic plaques were significantly more frequent in
aICAS than in sICAS (69.2 vs. 34.5%; p= 0.002).
DISCUSSION
The present study yielded the following main findings: (i) there
was a significant inverse correlation between the length and
degree of stenosis for sICAS≥70% but neither for sICAS<70%
nor for aICAS, (ii) sICAS<70% were insignificantly longer than
sICAS>70% (iii) sICAS<90% were significantly longer than
sICAS 90%, and (iv) sICAS was more likely associated with
echolucent plaques than aICAS.
There is substantial evidence that the degree of ICAS plays a
crucial role in the (re)occurrence of ischemic stroke (1). In line
with these findings, we also identified a higher degree of ICAS on
the symptomatic side.
Furthermore, we found that sICAS was more likely associated
with echolucent plaques than aICAS. Similar to our findings, a
large systemic review reported that echolucent plaques weremore
predominant among symptomatic than among asymptomatic
carotid stenosis (OR= 3.99, 95%CI= 3.06–5.19) (10). Moreover,
echolucent plaques of aICAS were shown to be associated with
an increased risk of future ischemic cerebrovascular events
(9). Histopathologically, echolucent plaques show increased
lipid content, macrophage density, and intraplaque hemorrhage,
whereas echogenic plaques have abundant fibrous tissue (16).
The risk of ICVE was found to be 6 times higher in relation
to the plaques with intraplaque hemorrhage compared to those
without hemorrhage, which corresponds to an annual stroke
incidence of 17.71% for the former vs. 2.43% for the latter (17).
Since echolucent plaques were more often detected on sICAS,
this plaque feature might contribute to the previous ICVEs in
our patients. This finding remained constant among all stenotic
degrees including ICAS<70%.
The inverse relationship between the length and degree of
sICAS≥70% might be explained by the early occurrence of
ischemic symptoms in patients with high-grade short segment
ICAS before the length increases. One might argue that longer
plaques result in emboli of atheromatous debris, while more
severe stenosis causes more severe flow disturbances, and thus
might generate emboli of platelet aggregates. This might also
point to different pathogenesis regarding the length and degree
of ICAS.
Buon et al. (18) found in young patients with ICAS<50%
that plaques of sICAS were significantly longer and more often
echolucent compared to aICAS. Interestingly, a plaque length
of 12 mm was the cut-off-value in the aforementioned study
favoring symptomatic rather than asymptomatic carotid artery
with a high sensitivity (86%) and specificity (73%). Of note,
the cut-off-value calculated in the present study was higher
(i.e., 16 mm). Furthermore, this threshold value yielded a lower
sensitivity (74%) and was not specific to discriminate between
symptomatic and asymptomatic stenosis (51%). However, Buon
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TABLE 1 | Baseline characteristics of stroke patients with stenosis of internal
carotid artery.
Characteristic Value
Age, median (interquartile range), mean (±SD) in
years
74(66–80) 72 (±10)
Male sex, n (%) 86 (71.1)
Hypertension, n (%) 108 (89.3)
Diabetes mellitus, n (%) 42 (34.7)
Smoking status, n (%)
Smoker 28 (23.5)
Ex-smoker 28 (23.5)
Non-smoker 63 (53)
Atrial fibrillation, n (%) 8(6,6)†
Duration of ECG monitoring in days, median (IQR) 5 (3-6)
Type of latest ischemic cerebrovascular event
Stroke, n (%) 88 (72.7)
TIA, n (%) 33 (27.3)
History of any previous ischemic cerebrovascular
event, either TIA or ischemic stroke, n (%)
32 (26)
Previous medications
Antiplatelets, n (%) 49 (56)
Anticoagulants, n (%) 18 (10.7)
Statin, n (%) 65 (38.7)
NIHSS-score on admission, median (IQR) 2 (0-4)
NIHSS on admission, n (%) ‡
0 20 (22.7)
1–4 41 (46.6)
5–8 13 (14.8)
9–12 7 (8)
13–17 7 (8)
HbA1c, median (IQR), mean (±SD) % 6 (5.6–6.5), 6.3 (±1.2)
Values are presented as mean median (interquartile range), mean (±standard deviation)
or number (%).
ECG, electrocardiography; IQR, interquartile range; TIA, transient ischemic attack.
†
Atrial fibrillation allowed only for patients with asymptomatic stenosis.
‡TIA patients are not included.
and coworkers investigated low-grade stenosis in much younger
stroke patients than our cohort and thus a comparison with our
data should be considered with caution.
Interestingly, previous authors measured the thickness of
carotid plaque for ICAS<50% among patients with embolic
stroke of undetermined source (19). The authors observed that
thickness of plaque ipsilateral to an ischemic cerebrovascular
stroke was more prominent than that on the contralateral side.
In the current study, sICAS<70% were insignificantly longer
than sICAS≥70% and sICAS<90%were significantly longer than
sICAS 90%. It might be postulated that plaque surface area,
represented by plaque length in our study and plaque thickness
in the aforementioned study, is larger among low-grade sICAS
compared to low-grade aICAS. We recommend the inclusion
of both parameters, i.e., plaque length and thickness, when
investigating the significance of plaques in respect to stroke
recurrence in future research.
Carotid revascularization has been shown to be the gold
standard treatment for patients with sICAS≥70% in order to
TABLE 2 | Different plaque characteristics among symptomatic and
asymptomatic internal carotid stenosis.
sICAS (n = 95) aICAS (n = 64) p-value
PLAQUE ECHOLUCENCY, n (%)†
Echolucent 38 (43.2 %) 15 (24.6 %) 0.02‡
Mixed 14 (15.9 %) 5 (8.2 %) 0.17‡
Echogenic 36 (40.9 %) 41 (67.2 %) 0.002‡
SEVERITY OF STENOSIS§
<70 %, n (%) 30 (31.9 %) 55 (87.3 %) <0.001||
≥70 %, n (%) 64 (68.1 %) 8 (12.7 %)
PLAQUE LENGTH IN DUPLEX, MEDIAN (IQR), mm
All degrees 17 (12–20) 16 (12–19) 0.66
ICAS <70 % 17 (15–20) 15 (12 –19) 0.14
ICAS ≥70 % 15 (12–19) 18 (11–20) 0.52
ICAS <90 % 16 (12–19) 18 (15–21) 0.03
ICAS 90 % 13 (10–16) 11, 21¶ ¶
Values are presented as median (interquartile range) or number (%).
aICAS: asymptomatic internal carotid artery stenosis, IQR, interquartile range, sICAS:
symptomatic internal carotid artery stenosis.
†
In 10 arteries, the available ultrasound images were insufficient to classify
plaque echolucency.
‡Statistical analysis for a difference between the mentioned type versus. both other
types.
§ In two arteries, the available ultrasound images were insufficient to classify the degree
of stenosis.
¶Difference between the distribution of ICAS<70% and ≥70% among sICAS and aICAS.
¶We had only two available arteries with asymptomatic 90% ICAS, hence statistical
analysis was not possible.
|| Difference between the distribution of ICAS<70% and ≥70% among sICAS and aICAS.
FIGURE 3 | Difference between the ultrasound-measured length of sICAS and
aICAS among patients with ICAS<70% vs. ICAS≥70%.
decrease the risk of ICVE recurrence (20–22). In patients with
moderate sICAS (i.e., 50–69%), carotid revascularization has
a marginal beneficial effect and in patients with low-grade
carotid stenosis (i.e. 30–49%) it has no effect (21). Future
Frontiers in Neurology | www.frontiersin.org 5 April 2019 | Volume 10 | Article 317
Elhfnawy et al. The Degree and Length of ICAS
FIGURE 4 | The relationship between the degree and length of sICAS
(symptomatic internal carotid artery stenosis). LOESS regression with a
smoothing parameter of 0.6 was used to produce the curve. N.b. For technical
reasons, 30% was used to represent 20–40% internal carotid stenosis; the
NASCET hemodynamic criteria does not differentiate between 20, 30, and
40% internal carotid stenosis.
FIGURE 5 | Difference between the ultrasound-measured length of sICAS and
aICAS among patients with ICAS<90% vs. ICAS 90%. N.b. We had only two
available arteries with aICAS 90%.
studies addressing the risk of ICVE recurrence related to
sICAS<70% should take the length of stenosis in consideration.
Moreover, it seems to be reasonable, to measure the length
of stenosis, when considering the treatment options for
those patients.
Up to now, it remains unclear whether patients with aICAS
are more likely to benefit from carotid revascularization or from
best medical treatment (23). In the 1990s, CEA has been shown to
be superior to Aspirin or deferral of any procedure (24, 25). Later
on, it was found that best medical treatment using antiplatelets,
statins, smoking cessation, exercise, implementation of a
Mediterranean diet and optimal blood pressure management
can achieve a significant reduction of cardiovascular events,
rate of plaque progression and microembolic signals as shown
in the transcranial duplex among patients with aICAS≥60%
(26). Moreover, carotid artery stenting was shown to improve
the cognition in patients with aICAS (27). In our study, ICAS
90% developed ICVE with yet a short length and ICAS<90%
developed their ischemic events after growing in length, hence
the length of ICAS represents a new parameter, which should be
further examined in large interventional studies to assess whether
conservative, CEA or carotid artery stenting is the treatment of
choice for these patients.
Several studies have reported that severely stenotic ICAS
might remain asymptomatic over years (28). Among patients
with aICAS 50–69%, progression of the stenosis was found to
be associated with the development of ipsilateral ischemic events
(29). Whether the length of stenosis can predict the long-term
prognosis or is related to cognitive deficits remains a matter for
future research. Furthermore, follow-up of the length of ICAS
may be a subject for further studies.
In addition, we found that the length of ICAS was longer
in duplex ultrasonography followed by DSA, whereas the
length was shortest in MRA. The difference in the length
between different examination modalities can be explained
by the expected underestimation of the length in MRA
and better visualization of the whole length in ultrasound,
which can be attributed to the ability to visualize the inner
vascular wall demonstrating the whole stenotic plaque in
ultrasound examinations. A statistically significant positive
correlation was found between the measurement of the length
in duplex sonography and MRA and, maybe because of
the small number (n = 14), only a trend for a positive
correlation was found between MRA and DSA. The correlation
between the measurement in duplex sonography and DSA
(n = 14) was not statistically significant. The aforementioned
explanation for the difference in the length between different
examination modalities, (i.e., measurement of the greatest
length of stenosis using duplex sonography, followed by DSA
and thereafter MRA), may explain in part the difference
in correlations.
Study Limitations
There are limitations of this study. The non-randomized design
of this single-center cross-sectional retrospective study with
a convenient sample may have influenced the comparative
analysis between aICAS and sICAS, and thus could have
resulted in biases. Another limitation of this study is that
a single observer (AME) assessed plaque echolucency and
length. The reliability and the inter-reader reproducibility of
the above-mentioned method, which we used to measure
the length of ICAS has to be assessed in further studies.
Another disadvantage of our study is that there was a
predominance of sICAS in comparison to aICAS, according
to our definition, as only patients with stroke or TIA
were included.
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CONCLUSION
Among patients with sICAS≥70%, the degree and length of
stenosis were inversely correlated. The ultrasound-measured
length of sICAS<70% was insignificantly longer than that of
sICAS≥70%, while that of sICAS<90% was significantly longer
than sICAS 90%. Echolucent plaque morphology is associated
with higher risk for cerebrovascular events. However, these
findings have to be confirmed in larger prospective studies.
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